Intravitreal Melphalan for Treatment of Primary Vitreoretinal Lymphoma: A New Indication for an Old Drug. [PDF]
Mashayekhi, Arman +3 more
core +1 more source
Ten-Year Follow-Up of Visual Outcomes After Vitrectomy for Clinically Non-Tractional Diabetic Macular Edema. [PDF]
Kumagai K +3 more
europepmc +1 more source
Macular Edema in Diabetic Neovascular Glaucoma and Its Association with Systemic Diseases. [PDF]
Kang K, Kang KT, Kim YC.
europepmc +1 more source
Treatment Trends of Diabetic Macular Edema in Korea (TRACK) Study: A Prospective Multicenter Study. [PDF]
Kim MS +22 more
europepmc +1 more source
Efficacy and Safety of Faricimab in Diabetic Macular Edema: Real-World Outcomes in Treatment-Naïve and Previously Treated Eyes. [PDF]
Esteban-Floría O +9 more
europepmc +1 more source
Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings? [PDF]
Peto T +5 more
europepmc +1 more source
Comments on "Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema". [PDF]
Yang Y, Zhang J.
europepmc +1 more source
Trends in diabetic macular edema therapy at a single academic institution
Levi N. Kanu +6 more
openalex +1 more source
Plasma metabolomic profiling of diabetic macular edema. [PDF]
Wang ZY +6 more
europepmc +1 more source
Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes. [PDF]
Murao F +15 more
europepmc +1 more source

